---
title: "Runben Biotechnology issued a profit forecast, expecting an annual net profit of 300 million to 310 million yuan, a year-on-year increase of 32.73% to 37.15%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/225797848.md"
description: "Runben Biotechnology expects a net profit of 300 million to 310 million yuan for the year 2024, a year-on-year increase of 32.73% to 37.15%. The company is actively expanding online and offline channels, increasing R&D investment, expanding baby care and mosquito repellent products, and enhancing overall profitability"
datetime: "2025-01-22T08:05:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/225797848.md)
  - [en](https://longbridge.com/en/news/225797848.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/225797848.md)
generator: "portal-rs"
---

# Runben Biotechnology issued a profit forecast, expecting an annual net profit of 300 million to 310 million yuan, a year-on-year increase of 32.73% to 37.15%

According to the Zhitong Finance APP, Runben Biotechnology (603193.SH) disclosed its performance forecast for 2024, expecting a net profit attributable to the parent company's owners to be between 300 million and 310 million yuan, a year-on-year increase of 32.73% to 37.15%.

During the reporting period, the company actively promoted the expansion of online and offline channels, increased R&D investment, further expanded the categories of infant care and mosquito repellent products, enriched the product matrix, and achieved significant economies of scale, resulting in an overall improvement in the company's profitability

### Related Stocks

- [603193.CN](https://longbridge.com/en/quote/603193.CN.md)
- [300959.CN](https://longbridge.com/en/quote/300959.CN.md)

## Related News & Research

- [If I could invest $500 in just 1 ETF in September, here's what I'd buy](https://longbridge.com/en/news/298347627.md)
- [REG - Panmure Liberum Ltd. Applied Nutrition - Proposed Secondary Placing in Applied Nutrition](https://longbridge.com/en/news/298619784.md)
- [Havas, linked to Louis Hachette director Yannick Bolloré, purchases EUR 5.31 million of Louis Hachette Group shares](https://longbridge.com/en/news/298621675.md)
- [Do These 3 Checks Before Buying Farmaceutica REMEDIA S.A. (BVB:RMAH) For Its Upcoming Dividend](https://longbridge.com/en/news/298536935.md)
- [YieldMax CVNA Option Income Strategy ETF declares $0.2618 dividend](https://longbridge.com/en/news/298601044.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**